Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options

In value terms, M&A activity in Singapore increased by 786% in Q2 2023 compared with the previous quarter’s total of $6.6m and fell by 83%

As­traZeneca an­nounced ear­ly Fri­day morn­ing that it is stop­ping work on two late-stage tri­als de­signed to gath­er val­ue-added ev­i­dence for Lokel­ma in hy­per­kalemia, a chron­ic